MarketScreener Editorial Features Vanda Pharmaceuticals Inc.
Equities
VNDA
US9216591084
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.390 USD | -0.62% |
|
0.00% | -27.55% |
| May. 07 | Vanda Pharmaceuticals Inc., Q1 2026 Earnings Call, May 06, 2026 | |
| May. 06 | Vanda Pharmaceuticals Inc. Raises Revenue Guidance for the Full-Year 2026 | CI |
MarketScreener Editorial Features
Search
No results for this search
- Stock Market
- Equities
- VNDA Stock
- News Vanda Pharmaceuticals Inc.
- MarketScreener Editorial Features
Select your edition
All financial news and data tailored to specific country editions
